Despite the well-known role of TP53 in different types of cancer, the role of SUZ12 was assessed in the last decade: alterations and losses in the polycomb repressive complex 2, of which SUZ12 is a key component, cause signaling dysregulation and contribute to oncogenesis through cell proliferation and growth [44,45]. Here, TP53 is linked to cancer.